Journal of Advances in Developmental Research

E-ISSN: 0976-4844   •   Impact Factor: 9.71

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 17 Issue 1 January-June 2026 Submit your research before last 3 days of June to publish your research paper in the issue of January-June.
Submit Research Paper Join as a Reviewer

Plagiarism is checked by the leading plagiarism checker TurnItIn

Call for Paper

Volume 17 Issue 1
2026

Submit your research paper

Indexing Partners
Academia Advanced Sciences Index Bielefeld Academic Search Engine CiteSeer DRJI Google Scholar Independent Search Engine & Directory Network ISI (International Scientific Indexing) Issuu Mendeley Research Networks
RefSeek ResearcherId - Thomson Reuters ResearchGate Scirus Scribd Semantic Scholar UTeM - Universiti Teknikal Malaysia Melaka Wiki for Call for Papers WorldCat Zenodo

Beyond Psychedelic Microdosing: Therapeutic Potential, Neuropharmacology, and Safety Considerations in Low-Dose Psychoactive Use

Author(s) Dr. Elias Rubenstein
Country United States
Abstract Microdosing and related low-dose psychoactive practices have become increasingly visible in discussions of mental health, cognition, creativity, emotional regulation, pain, sleep, spirituality, and psychological flexibility. However, the term microdosing is often used as if it referred to a single pharmacological phenomenon. More precisely, it describes a low-dose application pattern used across substances with different receptor mechanisms, experiential profiles, therapeutic hypotheses, evidence levels, and safety considerations.
This article presents a conceptual and comparative review of psychedelic and psychedelic-adjacent low-dose psychoactive use. It examines classical psychedelics, dissociatives, empathogens, monoamine oxidase inhibitor-containing preparations, non-serotonergic mushroom-derived compounds, natural psychoactive matrices, isolated or synthetic pharmacological comparators, supplement-stacked practices, and relevant co-use variables. Rather than evaluating these substances through generalized assumptions of either benefit or harm, the article classifies them according to therapeutic plausibility, pharmacological mechanism, dose-response relationship, perceptibility, tolerance, neuroplasticity, contextual modulation, interaction potential, product standardization, natural-matrix complexity, and strength of evidence.
The article argues that such classification is not optional but necessary. Without separating substance class, material form, dose-response, perceptibility, context, co-use, and evidence strength, microdosing research cannot produce interpretable or scientifically meaningful conclusions.
Keywords Psychedelic microdosing, low-dose psychoactive use, psilocybin, LSD, ketamine, Amanita muscaria, ayahuasca, Syrian rue, Kanna, 5-HTP, MDMA, mescaline, 4-AcO-DMT, coca leaf, cocaine, amphetamine, alcohol, neuroplasticity, expectancy, placebo, neuropharmacology, therapeutic potential, natural products, drug interactions, psychopharmacology
Field Sociology > Health
Published In Volume 17, Issue 1, January-June 2026
Published On 2026-06-18
View / Download PDF File

Share this



CrossRef

CrossRef DOI is assigned to each research paper published in our journal.

IJAIDR DOI prefix is
10.71097/IJAIDR

Downloads
Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 17 Isu 1Cover Page Vol 16 Isu 2Cover Page Vol 16 Isu 1

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA Open Access

About IJAIDR
Fees & Payment
Current Issue
Publication Archive 		Submit Research Paper
Track Submission Status
Publication Guidelines
Peer Review & Plagiarism 		Join as a Reviewer
Editors & Reviewers
Get Reviewer Membership Certi. 		Website/Journal Policies
Usage Policy
Content Policies
Privacy Policy
Contact Us Message on WhatsApp +91-9687-182-185 editor@ijaidr.com